AltPep
Amy C., currently working at AltPep as an Assistant to CEO and Special Projects Manager, previously held roles such as Director of Clinical and Commercial Operations at Bertis Bioscience and VP of Client Services at IntuitiveX. With a background in bioengineering and experience in various research and consulting positions, Amy brings a wealth of knowledge to the life sciences industry. Amy's expertise includes strategic planning, market evaluation, product positioning, and regulatory guidance, making their a valuable asset in driving innovation and commercialization in the healthcare and biotech space.
AltPep
AltPep Corporation is a biomedical startup with a breakthrough approach for diagnosing and treating some of the world’s most intractable diseases: amyloid diseases. They are currently focusing on CNS disorders, in particular Alzheimer’s Disease (AD). They target and seek to neutralize the early toxic oligomers behind these amyloid diseases, which in the case of AD are due to aggregation of the Amyloid-beta peptide (Abeta).